Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia.

Document type:: Letter; Letter
Author(s):: Müller-Thomas, Catharina; Rudelius, Martina; Rondak, Ina-Christine; Haferlach, Torsten; Schanz, Julie; Huberle, Christina; Schmidt, Burkhard; Blaser, Rainer; Kremer, Marcus; Peschel, Christian; Germing, Ulrich; Platzbecker, Uwe; Götze, Katharina
Title:: Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia.
Journal title abbreviation:: Haematologica
Year:: 2014
Journal volume:: 99
Journal issue:: 10
Pages contribution:: e179-81
Language:: eng
Fulltext / DOI:: doi:10.3324/haematol.2014.104760
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/24972774
Print-ISSN:: 0390-6078
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie); Institut für Medizinische Statistik und Epidemiologie
BibTeX